Showing results (491-500 of 1,151) with videos related to

Sort By:
Pageof 116
Journal of Hepatology|September 23, 2022
Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosisAlberto Zanetto, Filippo Pelizzaro, Elena Campello, et al.
International Journal of Molecular Sciences|February 25, 2023
Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome AssociationBarbara Kneis, Stefan Wirtz, Klaus Weber, et al.
Hepatology Communications|February 7, 2018
Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosisMichael Praktiknjo, Jennifer Lehmann, Mette J Nielsen, et al.
Radiology|August 19, 2020
Myocardial Fibrosis and Inflammation in Liver Cirrhosis: MRI Study of the Liver-Heart AxisAlexander Isaak, Michael Praktiknjo, Christian Jansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2024
Impaired HBsAg release and antiproliferative/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary processMichael Basic, Keerthihan Thiyagarajah, Mirco Glitscher, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2006
Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver diseaseFrank Tacke, Kai Fiedler, Mario von Depka, et al.
Scientific Reports|October 24, 2024
Leveraging weak complementary labels enhances semantic segmentation of hepatocellular carcinoma and intrahepatic cholangiocarcinomaMiriam Hägele, Johannes Eschrich, Lukas Ruff, et al.
Plos Pathogens|January 10, 2013
TNFα-mediated liver destruction by Kupffer cells and Ly6Chi monocytes during Entamoeba histolytica infectionElena Helk, Hannah Bernin, Thomas Ernst, et al.
International Journal of Environmental Research and Public Health|January 18, 2020
Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis EMarten Schulz, Paula Biedermann, Claus-Thomas Bock, et al.
Pageof 116